News from endo international plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Making a selection with these dropdown will cause content on this page to change. News listings will update as each option is selected.

Latest

Mar 26, 2024, 07:30 ET Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®

Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 mg tablets, a generic version of Amgen's...

Mar 19, 2024, 17:30 ET Endo Announces Confirmation of Plan of Reorganization

Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced that the United States Bankruptcy Court for the Southern District of New York has confirmed its Chapter 11 plan of...

Mar 06, 2024, 16:15 ET ENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS

Endo International plc (OTC: ENDPQ) today reported financial results for the fourth-quarter ended December 31, 2023. FOURTH-QUARTER FINANCIAL PERFORMANCE (in thousands, except per share amounts)...

Feb 29, 2024, 11:43 ET Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER

Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced that its subsidiary, Endo Health Solutions Inc. ("EHSI"), has agreed to resolve all issues regarding previously disclosed ...

Jan 24, 2024, 07:30 ET Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open

Endo International plc (OTC: ENDPQ) announced today that the peer-reviewed Journal of Hand Surgery Global Open published Collagenase Clostridium Histolyticum for the Treatment of Dupuytren Disease: A ...

Jan 22, 2024, 16:30 ET Endo's Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada

Paladin Labs Inc., a subsidiary of Endo International plc (OTC: ENDPQ), announced today that XCOPRI® (cenobamate tablets) is now available in Canada. XCOPRI is indicated as adjunctive therapy in the...

Jan 19, 2024, 07:30 ET Endo Announces New Data for Dupuytren's Contracture Presented at the American Association for Hand Surgery Annual Meeting

Endo International plc (OTC: ENDPQ) announced today that two new presentations related to Dupuytren's contracture and XIAFLEX® (collagenase clostridium histolyticum) were shared during the American...

Dec 19, 2023, 13:27 ET ENDO FILES PLAN OF REORGANIZATION TO IMPLEMENT PREVIOUSLY ANNOUNCED SALE TRANSACTION

Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced that it has taken an important step toward concluding its financial restructuring process by filing a proposed Plan of...

Nov 30, 2023, 07:30 ET Endo Launches Unscripted Video Series With Real Peyronie's Disease Patients

Endo International plc (OTC: ENDPQ) announced today the launch of its new branded video series, PD Pool Hall, which aims to educate people about Peyronie's disease (PD), a men's health condition that ...

Nov 16, 2023, 07:30 ET Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting

Endo International plc (OTC: ENDPQ) announced today that five new presentations related to Peyronie's disease, or PD, and XIAFLEX® (collagenase clostridium histolyticum, or CCH, injection 0.9 mg)...

Nov 06, 2023, 16:05 ET ENDO REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS

Endo International plc (OTC: ENDPQ) today reported financial results for the third-quarter ended September 30, 2023. THIRD-QUARTER FINANCIAL PERFORMANCE (in thousands, except per share amounts) Three ...

Nov 02, 2023, 07:30 ET Endo Launches Colchicine Capsules, Generic Version of MITIGARE®

Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping colchicine 0.6 mg capsules, a generic version of Hikma's...

Sep 21, 2023, 07:45 ET Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting

Endo International plc (OTC: ENDPQ) announced today that data from clinical studies of collagenase clostridium histolyticum (CCH) in patients with plantar fibromatosis will be presented during the...

Aug 08, 2023, 07:45 ET ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS

Endo International plc (OTC: ENDPQ) today reported financial results for the second-quarter ended June 30, 2023. SECOND-QUARTER FINANCIAL PERFORMANCE (in thousands, except per share amounts) Three...

Jul 20, 2023, 07:30 ET Endo Announces First Patient Enrolled in Registry of Peyronie's Disease

Endo International plc (OTC: ENDPQ) announced today that the first patient has been enrolled in CURVE-PD (Clinical Understanding through Real-world data to Validate Effectiveness of treatments in...

Jul 18, 2023, 16:30 ET Endo Launches Bivalirudin Injection in Ready-to-Use Vials

Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping bivalirudin injection in a ready-to-use 250 mg/50 mL single-use vial. It is the only...

Jul 17, 2023, 16:30 ET Endo and Premier, Inc. Collaborate to Address Pitocin® (oxytocin injection, USP) Shortage

Endo International plc (OTC: ENDPQ) and Premier, Inc. (NASDAQ: PINC) announced today that Endo's Par Sterile Products business will supply Pitocin® (oxytocin injection, USP) vials through Premier's...

Jul 13, 2023, 16:30 ET Endo Presents New Data at the American Podiatric Medical Association Annual Meeting

Endo International plc (OTC: ENDPQ) announced today that new data from a Phase 1 study of collagenase clostridium histolyticum (CCH) in patients with plantar fibromatosis will be presented during the ...

Jun 29, 2023, 16:30 ET Endo Launches First Generic Version of Noxafil® (posaconazole) Injection

Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping posaconazole injection (18 mg/mL), the first generic version of Merck's Noxafil® in the U....

Jun 29, 2023, 07:30 ET Endo Announces Approval of XCOPRI™ (cenobamate tablets) in Canada

Endo International plc (OTC: ENDPQ) announced today that Paladin Labs Inc., an Endo operating company, received Health Canada's approval of XCOPRI™ (cenobamate tablets) for adjunctive therapy in the...

Jun 26, 2023, 07:30 ET Endo Announces First Patient Enrolled in Registry of Dupuytren's Contracture

Endo International plc (OTC: ENDPQ) announced today that the first patient has been enrolled in GRASP-DC (Generating Real-world Ambispective data to Study Participant Treatment outcomes for...

Jun 15, 2023, 07:30 ET Endo Launches Dexlansoprazole Capsules, Generic Version of Dexilant®

Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping dexlansoprazole 30 mg capsules, a generic version of Takeda's...

Jun 12, 2023, 07:30 ET Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe

Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection) pre-filled syringe, the ...

Jun 05, 2023, 07:30 ET Endo Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Data Analysis in Peer-Reviewed Urology®

Endo International plc (OTC: ENDPQ) announced today that post-hoc data from two Phase 3 studies of XIAFLEX® (collagenase clostridium histolyticum, or CCH, injection 0.9 mg) in treating men with...

May 24, 2023, 07:30 ET Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials

Endo International plc (OTC: ENDPQ) announced today that its subsidiary Endo Ventures Limited has executed an agreement with MAIA Pharmaceuticals, Inc. to distribute bivalirudin injection in a...

Journalists and Bloggers

The news you need, when you need it.

Join PR Newswire for Journalists to access all of the free services designated to make your job easier.

In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.

LEARN MORE
Making a selection with these dropdown will cause content on this page to change. News listings will update as each option is selected.